Physician profile
Roger A Sacry
NPI 1528009529
$1,068.49
in general payments reported to CMS, 2019-2025
18 companies · $13.49 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $179 · 2023: $81.07 · 2024: $17.90 · 2025: $13.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $143.19 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $122.63 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.03 | 2019-2020 | |
| Abbvie INC. | $112.46 | 2023-2025 | |
| Amgen INC. | $83.00 | 2019-2020 | |
| Allergan, INC. | $65.42 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $56.79 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.56 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $52.69 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.64 | 2019 | |
| Merck Sharp & Dohme LLC | $45.11 | 2019 | |
| Lilly USA, LLC | $39.57 | 2019 | |
| Pfizer INC. | $36.64 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $22.86 | 2019 | |
| Glaxosmithkline, LLC. | $22.30 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.47 | 2019 | |
| Sanofi Pasteur INC. | $12.17 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Sacry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.